Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.44M 1.33M 1.24M 2.33M 155M 2.37M 15.93M 6.17M 76.31M 6.16M 6.03M 265M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.14M 6.58M 6.15M 11.54M 767M 11.75M 78.93M 30.57M 378M 30.53M 29.86M 1.31B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-99.50%-.--% - - 3.65K
+0.93%+2.65%+42.33%+145.77% 1,006B
+1.61%+7.22%+60.81%+47.98% 589B
+3.51%+12.31%+31.15%+78.88% 430B
-0.92%+5.11%+29.26%+21.27% 331B
-0.63%+5.49%+37.62%+23.63% 288B
-1.33%+5.04%+29.41%+39.74% 285B
-2.63%+4.85%-28.73%-42.86% 213B
+0.40%+4.51%+25.85%+55.35% 190B
-1.05%+0.06%+16.91%+59.86% 154B
Average -10.11%+5.96%+27.18%+47.74% 387.31B
Weighted average by Cap. +0.22%+5.38%+35.03%+70.16%

Financials

2007 2008
Net sales 23.47M 20.61M 18.99M 17.76M 33.3M 2.21B 33.92M 228M 88.26M 1.09B 88.12M 86.19M 3.79B 25.96M 22.8M 21.01M 19.64M 36.84M 2.45B 37.52M 252M 97.64M 1.21B 97.49M 95.35M 4.2B
Net income -20.86M -18.32M -16.88M -15.78M -29.6M -1.97B -30.15M -203M -78.45M -970M -78.33M -76.61M -3.37B -4.01M -3.52M -3.24M -3.03M -5.69M -378M -5.79M -38.9M -15.07M -186M -15.04M -14.71M -648M
Net Debt 18.79M 16.51M 15.21M 14.22M 26.67M 1.77B 27.16M 182M 70.67M 874M 70.56M 69.02M 3.04B 6.49M 5.7M 5.25M 4.91M 9.21M 612M 9.38M 63M 24.4M 302M 24.37M 23.83M 1.05B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
-